- Details
- Computational Cardiology
The human induced pluripotent stem cell (hiPSC) technology, discovered in the 2000s, allows us to induce pluripotency and produce stem cells directly from healthy donors and patients. hiPSC-derived cardiomyocytes (hiPSC-CMs) are cardiac cells differentiated from hiPSCs, and they represent a potentially infinite pool of human patient- and disease-specific in vitro models for cardiac studies. Their...
